Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ACLX
Arcellx, Inc.
Healthcare | Biotechnology
$115.07+0.00 (+0.00%)as of 2026-07-14 21:20 UTC
Market Cap$6.7B
Volume13.19M
EPS (TTM)$-4.07
Arcellx, Inc. (NASDAQ: ACLX) is a $6.7B biotechnology company trading at $115.07. Figures from SEC EDGAR and market feeds; updated 2026-07-14 21:20 UTC.
52-Week Range
Low $47.86High $115.13
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Arcellx, Inc. is a biotechnology company, listed on NASDAQ as ACLX.
What is ACLX's valuation?
ACLX trades at $115.07, as of 2026-07-14.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-07-14 21:20 UTC. This page is also available as JSON at /api/data?ticker=ACLX and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ACLX and 3,500+ tickers.